Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02991651
Title Study of IRX4204 With Erlotinib in Previously Treated Advanced NSCLC
Recruitment Suspended
Gender both
Phase Phase I
Variant Requirements No
Sponsors Io Therapeutics

lung non-small cell carcinoma


Erlotinib + IRX4204

Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.